×
For best experience we recommend to activate Javascript in your browser.
Diazepam Binding Inhibitor antibody (AA 2-105)
This anti-Diazepam Binding Inhibitor antibody is a Rabbit Polyclonal antibody detecting Diazepam Binding Inhibitor in IHC and ELISA. Suitable for Human.
Quick Overview for Diazepam Binding Inhibitor antibody (AA 2-105) (ABIN7615857)
Target
See all Diazepam Binding Inhibitor (DBI) Antibodies
Diazepam Binding Inhibitor (DBI)
Reactivity
All reactivities for Diazepam Binding Inhibitor antibodies
Human
Host
All hosts for Diazepam Binding Inhibitor antibodies
Rabbit
Clonality
All clonalities for Diazepam Binding Inhibitor antibodies
Polyclonal
Conjugate
All conjugates for Diazepam Binding Inhibitor antibodies
This Diazepam Binding Inhibitor antibody is un-conjugated
Application
All applications for Diazepam Binding Inhibitor antibodies
Immunohistochemistry (IHC), ELISA
Product Details anti-Diazepam Binding Inhibitor Antibody
(hide)
Binding Specificity
All epitopes for Diazepam Binding Inhibitor antibodies
AA 2-105
Purpose
Dbi Polyclonal Antibody
Characteristics
The Dbi Polyclonal Antibody (Species: Human) has been validated for the following applications: ELISA, IHC.
Purification
Protein G Purified
Purity
>95%
Immunogen
Recombinant Human Acyl-Coa-Binding Protein
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
Lot specific
Buffer
Preservative: 0.03 % Proclin 300, Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for Diazepam Binding Inhibitor
(hide)
Target
Diazepam Binding Inhibitor (DBI)
Alternative Name
DBI
UniProt
P07108
Recently viewed
(hide)
Chat with us , powered by LiveChat